European equities traded in the US as American depositary receipts were moving sharply lower late Tuesday morning, falling 1.21% to 1,404.91 on the S&P Europe Select ADR Index.
From continental Europe, the gainers were led by biopharmaceutical company DBV Technologies (DBVT) and biotech firm BioNTech (BNTX), which rose 2.6% and 2.3%, respectively. They were followed by semiconductor company Sequans Communications (SQNS) and furniture maker Natuzzi (NTZ), which were down 1.5% and 1.4%, respectively.
The decliners from continental Europe were led by telecommunications company VEON (VEON) and medical device maker EDAP TMS (EDAP), which retreated 6.9% and 3.5%, respectively. Biopharmaceutical firm Grifols (GRFS) lost 3.3% and financial services company Banco Santander (SAN) was down 2.8%.
From the UK and Ireland, the gainers were led by biopharmaceutical companies Akari Therapeutics (AKTX) and TC Biopharm (TCBP), which advanced 8.5% and 3.9%, respectively. They were followed by biopharmaceutical companies Bicycle Therapeutics (BCYC) and Mereo BioPharma Group (MREO), which rose 3.6% and 2.3%, respectively.
The decliners from the UK and Ireland were led by financial services companies Barclays (BCS) and Lloyds Banking Group (LYG), which fell 3% and 2.8%, respectively. Biopharmceutical company NuCana (NCNA) was down 2.6% and financial services company HSBC (HSBC) lost 2.3%.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。